Morningstar | Monash IVF is well positioned to benefit from growing social acceptance of infertility therapies.
Monash IVF Group is a major provider of in vitro fertilisation, or IVF, services with 23% of the national market. It's one of two pure plays listed on the Australian Securities Exchange. Notwithstanding significant market share in Victoria and an expanding presence in New South Wales, Monash is underrepresented in higher-growth markets on Australia's east coast. The IVF market is characterised by a relatively small pool of fertility specialists nationwide, exposing all players to key personnel risk. Contractual agreements, structured as evergreen deals with 12-month notice periods, add to this risk should competitors offer more attractive remuneration terms.Healthbridge Enterprises is engaged in the provision of medical services in the area of human reproduction and human pathology.
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.